Not registered yet?
Registration is free, quick and easy. You'll get more access to our content and extra features such as commenting and personalised newsletters.
Register now
Access to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
Delivering gene therapy
After some well-publicised problems, gene therapy – delivering DNA into people’s cells using viruses – is booming, Anthony King finds
FDA asks Endo to take pain drug off market
Request part of larger strategy to address opioid misuse in the US
J&J licenses Protagonist’s inflammatory bowel peptide
Potential first-in-class treatment is just about to enter clinical trials
Explosion kills 10 at Chinese petrochemical plant
Nine others injured when gas tanker exploded in loading area
Ineos expands North Sea oil and gas operations
Purchase of Danish Dong Energy and BP’s Forties pipeline will feed Grangemouth refinery
US supreme court limits patent rights
Biotech industry is concerned that ruling will hit small companies
Dow will face dioxin suit
US appeals court rules property owners have a valid case over soil contamination
Age old problems
Two stories of young and older academics facing careers hurdles
Should older academics be forced to retire?
Why some universities are requiring staff to step down
Is Macron's offer too good to be true?
France’s grant pledge to scientists is a new kind of recruitment
'How pragmatic is it to be a blind scientist?’
Mona Minkara on not letting loss of vision end her science ambitions
Walking the Planck: the most-pirated chemistry journals on Sci-Hub
Papers from Nature have been downloaded over 234,000 times from Sci-Hub, making it the most-pirated journal on the site
Chemistry's piracy problem
‘Black’ open access is forcing a shake-up of chemistry journal publishing
